A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, found that the diabetes drug metformin works in a different way than previously...
Search This Blog
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Showing posts with label drug. Show all posts
Showing posts with label drug. Show all posts
Two Takeda Diabetes Drug Applications, FDA Asks For More Info
Takeda says it has received a complete response letter from the FDA regarding NDAs (new drug applications) for alogliptin and fixed-dose combination alogliptin and pioglitazone - both diabetes type 2 investigational therapies. Takeda says it has recently been providing the FDA (Food and Drug Administration) with post marketing data from markets outside the USA. Takeda believes it can provide the additional...
The First Step of a Thousand Miles
My family has serious issues with drug and alcohol addiction. Mary, my sister introduced the family to this dark world when she was 13. She thought that it would be fun to prove how grown up she was to all of her friends by drinking so much that she had to be rushed to the hospital to have her stomach pumped. Of course mom and dad punished her by taking away her TV and phone privileges but that didn’t...
Statin Labels Updated to Include Diabetes, Memory, and Drug Interaction Risks
Michael
12:45 PM
diabetes, drug, Medical Review, Medical Studies, memory loss, risk, Statin Labels
No comments
The FDA is making several changes to the labels of statins following a comprehensive review, the agency announced on Tuesday: Incident diabetes and increased blood glucose are possible with statin use. Several meta-analyses found an increased risk for diabetes (9%–13%) in patients taking statins. Reversible memory loss and confusion are possible, though rare. The FDA said there is no evidence that...
Diabetes Drug Shows Promise in Reducing Risk of Cancer, Study Suggests
An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and human-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James...